On March 10, 2025, Cuu Long Pharmaceutical Joint Stock Company successfully organized the EU-GMP seminar with the theme “Expert Consultation – Practical Dialogue.”
This special event gathered experienced experts from Vietnam and India to share knowledge, discuss, and offer practical solutions to Cuu Long Pharmaceuticals in the process of building and applying EU-GMP standards.
The event was attended by Mr. Nguyen Van Ban – CEO of F.I.T Group; Mrs. Nguyen Thi Thu Huong – CEO of Benovas Pharmaceutical JSC and Assistant to the Chairman of the Board of Directors; Mr. Nguyen Trong Duc – Deputy CEO of Production & SC Cuu Long Pharmaceuticals; Mr. Nguyen Ba The – Business Development Director; Mr. Do Minh Si – Technical Director (QA, QC, R&D). The expert delegation was led by Mr. Dao Xuan Huong – Chairman of the Board of Directors of GMPC Vietnam JSC, and the Indian expert delegation was led by Mr. Rohit Ochaney – Co-founder and CEO of Inotek India.
“This seminar is also an opportunity for us to connect and share practical experiences, creating a solid foundation for the sustainable development of the pharmaceutical manufacturing industry, while promoting the transformation and improvement of product quality to meet international standards most effectively,” said Mrs. Nguyen Thi Thu Huong – CEO of Benovas Pharmaceutical JSC and Assistant to the Chairman of the Board of Directors, who also oversees internal operations at Cuu Long Pharmaceuticals.
The seminar was divided into two sessions:
In the first session of the seminar, Mr. Rohit Ochaney – Co-founder and CEO of Inotek India presented on the topic “Why adopting EU-GMP standards is an inevitable factor in the pharmaceutical industry of the 21st century?” He delved into the reasons why EU-GMP standards are not only a quality requirement but also a key factor in enhancing the competitiveness of pharmaceutical companies in the international market.
Also at the seminar, Mr. Dao Xuan Huong – Chairman of the Board of Directors of GMPC Vietnam JSC shared his heartfelt experiences in investing and building EU-GMP certified factories in Vietnam.
The second session of the seminar featured an impressive roundtable dialogue format, with experts Mr. Dao Xuan Huong, Mr. Rohit Ochaney, and two experts from Cuu Long Pharmaceuticals: Mr. Do Minh Si – Technical Director (QA, QC, R&D), and Mr. Mai Khac Tung – Assistant to the Chairman of the Board of Directors.
Specialists from the QA, QC, R&D departments, and Investment Construction Management directly discussed with the four experts on various issues related to ensuring the quality management system, meeting quality control requirements throughout the entire production chain, finding new methods and technologies to improve the accuracy of product quality testing, developing new products that fully comply with EU-GMP quality standards, and building and upgrading factory infrastructure to meet EU-GMP requirements.
After four hours of discussion, the seminar provided comprehensive solutions to address challenges in implementing and maintaining EU-GMP standards. This was also an opportunity for Cuu Long Pharmaceuticals and the expert delegation to exchange experiences in applying EU-GMP standards, thus strengthening the cooperation between the parties and opening new avenues for improving competitiveness and sustainable development.
With the knowledge and solutions shared during the seminar, Cuu Long Pharmaceuticals reinforced its ability to build and maintain EU-GMP certified factories that meet quality requirements, gradually moving towards realizing its vision of becoming the most highly regarded Vietnamese pharmaceutical company by patients, partners, and employees through innovative, accessible products and services.
Theo: Sức khỏe đời sống
